Atlas Trials

Programmed Death-Ligand1 Expression in Her-2 Positive and Triple Negative Breast Cancer

Clinical trial NCT05169853 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05169853
Sponsor
Ain Shams University
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Triple Negative Breast CancerHER2-positive Breast Cancer
Start date
2022-01-01
Primary completion
2024-10-30
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.